Early depletion of proliferating B cells of germinal center in rapidly progressive simian immunodeficiency virus infection.
暂无分享,去创建一个
J. Shiver | W. Schleif | E. Emini | M. Citron | D. Casimiro | X. Liang | T. Fu | M. Davies | Zhi-Qiang Zhang | L. Handt | Minchun Chen | Tong-Ming Fu | Danilo R Casimiro | John W Shiver | Michael Citron | Xiaoping Liang | William A Schleif | Emilio A Emini | Mary-Ellen Davies | Larry Handt | Minchun Chen | Zhi-Qiang Zhang | Janine Burns | Janine A Burns
[1] Gabriela Canziani,et al. Rapid Progression to Simian AIDS Can Be Accompanied by Selection of CD4-Independent gp120 Variants with Impaired Ability To Bind CD4 , 2002, Journal of Virology.
[2] B. Connolly,et al. The impact of early immune destruction on the kinetics of postacute viral replication in rhesus monkey infected with the simian-human immunodeficiency virus 89.6P. , 2004, Virology.
[3] Philip R. Johnson,et al. Passive Immunotherapy in Simian Immunodeficiency Virus-Infected Macaques Accelerates the Development of Neutralizing Antibodies , 2004, Journal of Virology.
[4] Alan S. Perelson,et al. Quantitative Image Analysis of HIV-1 Infection in Lymphoid Tissue , 1996, Science.
[5] Anthony S. Fauci,et al. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease , 1993, Nature.
[6] D. Montefiori,et al. Effect of Humoral Immune Responses on Controlling Viremia during Primary Infection of Rhesus Monkeys with Simian Immunodeficiency Virus , 2003, Journal of Virology.
[7] D. Montefiori,et al. Determinants of disease in the simian immunodeficiency virus-infected rhesus macaque: characterizing animals with low antibody responses and rapid progression. , 1998, The Journal of general virology.
[8] J. Shiver,et al. Mamu-A*01 Allele-Mediated Attenuation of Disease Progression in Simian-Human Immunodeficiency Virus Infection , 2002, Journal of Virology.
[9] D. Nickle,et al. Human Immunodeficiency Virus Type 1 Bound to B Cells: Relationship to Virus Replicating in CD4+ T Cells and Circulating in Plasma , 2002, Journal of Virology.
[10] C. Cheng‐Mayer,et al. Antibody Protects Macaques against Vaginal Challenge with a Pathogenic R5 Simian/Human Immunodeficiency Virus at Serum Levels Giving Complete Neutralization In Vitro , 2001, Journal of Virology.
[11] M. Feinberg. Changing the natural history of HIV disease , 1996, The Lancet.
[12] J. Mascola,et al. Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies , 2000, Nature Medicine.
[13] D. Montefiori,et al. Immune Failure in the Absence of Profound CD4+ T-Lymphocyte Depletion in Simian Immunodeficiency Virus-Infected Rapid Progressor Macaques , 2004, Journal of Virology.
[14] Steven M. Wolinsky,et al. Human immunodeficiency virus type 1 infection in homosexual men who remain seronegative for prolonged periods. , 1989, The New England journal of medicine.
[15] D. Shriner,et al. Divergent patterns of progression to AIDS after infection from the same source: human immunodeficiency virus type 1 evolution and antiviral responses , 1997, Journal of virology.
[16] N. Haigwood,et al. Determination of a Statistically Valid Neutralization Titer in Plasma That Confers Protection against Simian-Human Immunodeficiency Virus Challenge following Passive Transfer of High-Titered Neutralizing Antibodies , 2002, Journal of Virology.
[17] David C. Montefiori,et al. CD4+-T-Cell and CD20+-B-Cell Changes Predict Rapid Disease Progression after Simian-Human Immunodeficiency Virus Infection in Macaques , 1998, Journal of Virology.
[18] T. Chun,et al. HIV-1 induces phenotypic and functional perturbations of B cells in chronically infected individuals , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[19] J. Mascola,et al. Rapid disease progression without seroconversion following primary human immunodeficiency virus type 1 infection--evidence for highly susceptible human hosts. , 1997, The Journal of infectious diseases.
[20] J. Tew,et al. Microanatomy of lymphoid tissue during humoral immune responses: structure function relationships. , 1989, Annual review of immunology.
[21] N. Haigwood,et al. Plasma viremia in macaques infected with simian immunodeficiency virus: plasma viral load early in infection predicts survival , 1997, Journal of virology.
[22] J. van Lunzen,et al. Follicular dendritic cells retain HIV-1 particles on their plasma membrane, but are not productively infected in asymptomatic patients with follicular hyperplasia. , 1994, Journal of immunology.
[23] Anthony S. Fauci,et al. Host factors and the pathogenesis of HIV-induced disease , 1996, Nature.
[24] D. Richman,et al. Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells. , 1999, Science.
[25] Ashley T. Haase,et al. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS , 1993, Nature.
[26] O. Pickeral,et al. Decreased Survival of B Cells of HIV-viremic Patients Mediated by Altered Expression of Receptors of the TNF Superfamily , 2004, The Journal of experimental medicine.
[27] V. Maino,et al. Insufficient Production and Tissue Delivery of CD4+Memory T Cells in Rapidly Progressive Simian Immunodeficiency Virus Infection , 2004, The Journal of experimental medicine.
[28] T. Chun,et al. Perturbations in B cell responsiveness to CD4+ T cell help in HIV-infected individuals , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[29] A. Fauci,et al. Multifactorial nature of human immunodeficiency virus disease: implications for therapy. , 1993, Science.
[30] N. Haigwood,et al. Passive immune globulin therapy in the SIV/macaque model: early intervention can alter disease profile. , 1996, Immunology letters.
[31] D. Watkins,et al. Attenuation of Simian Immunodeficiency Virus SIVmac239 Infection by Prophylactic Immunization with DNA and Recombinant Adenoviral Vaccine Vectors Expressing Gag , 2005, Journal of Virology.
[32] Charles R. Brown,et al. CD8+ and CD20+ Lymphocytes Cooperate To Control Acute Simian Immunodeficiency Virus/Human Immunodeficiency Virus Chimeric Virus Infections in Rhesus Monkeys: Modulation by Major Histocompatibility Complex Genotype , 2005, Journal of Virology.
[33] Tahir A. Rizvi,et al. Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian–human immunodeficiency virus infection , 2000, Nature Medicine.
[34] T. Chun,et al. B Cells of HIV-1–Infected Patients Bind Virions through Cd21–Complement Interactions and Transmit Infectious Virus to Activated T Cells , 2000, The Journal of experimental medicine.
[35] P. Marx,et al. Retrospective analysis of viral load and SIV antibody responses in rhesus macaques infected with pathogenic SIV: predictive value for disease progression. , 1999, AIDS research and human retroviruses.
[36] P. Rácz,et al. Follicular dendritic cells initiate and maintain infection of the germinal centers by human immunodeficiency virus. , 1995, Current topics in microbiology and immunology.